Efficacy and safety of Symbicort (budesonide/formoterol) Turbuhaler as Single Therapy in subjects with moderate-severe asthma. Comparison with conventional asthma therapy, Pulmicort(budesonide) Turbuhaler as regular treatment complemented with Bricanyl(terbutaline) Turbuhaler.

Study identifier:SD-039-0668

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Efficacy and safety of Symbicort (budesonide/formoterol) Turbuhaler as Single Therapy in subjects with moderate-severe asthma. Comparison with conventional asthma therapy, Pulmicort(budesonide) Turbuhaler as regular treatment complemented with Bricanyl(terbutaline) Turbuhaler.

Medical condition

asthma

Phase

Phase 3

Healthy volunteers

-

Study drug

-

Sex

-

Actual Enrollment

-

Study type

Interventional

Age

-

Date

Study Start Date: 01 May 2001
Primary Completion Date: -
Study Completion Date: -

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2013 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria